Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  BioNano Genomics Closes $53 Million Funding Led by Legend Capital
  Yabao Pharma In-licenses China Rights to Parkinson's Drug Technology
  Amgen Completes $200 Million Biologics Facility in Singapore
  3SBio Gains Rights to Korean Cancer mAb for Emerging Countries
  Lee's Pharm In-licenses Neo-Natal Pulmonary Drug for China
  China Agrees to Cut Tariffs on Imported Medical Devices
  Suzhou Connect Biopharma Starts Phase I Trial of Autoimmune Drug
  Sino Biopharma Invests in Karolinska; Deals Ahead?
  BeiGene Raises $75 Million to Develop Oncology Drugs in China
  WuXi Reports Record Revenues, CapEx Spending
 
Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors